https://orcid.org/0000-0003-1928-7411
References
- Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6.
- Krebs MO, Bellon A, Mainguy G, et al. One-carbon metabolism and schizophrenia: current challenges and future directions. Trends Mol Med. 2009;15(12):562–570.
- Rifai N, Horvath AR. Tietz textbook of clinical chemistry and molecular diagnostics. St. Louis, MO: Elsevier; 2018.
- Green R. Indicators for assessing folate and vitamin B-12 status and for monitoring the efficacy of intervention strategies. Am J Clin Nutr. 2011;94(2):666S–672S.
- McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol. 1969;56(1):111–128.
- Kumar A, Palfrey HA, Pathak R, et al. The metabolism and significance of homocysteine in nutrition and health. Nutr Metab (Lond). 2017;14:78.
- Chrysant SG, Chrysant GS. The current status of homocysteine as a risk factor for cardiovascular disease: a mini review. Expert Rev Cardiovasc Ther. 2018;16(8):559–565.
- Azzini E, Ruggeri S, Polito A. Homocysteine: its possible emerging role in at-risk population groups. Int J Mol Sci. 2020;21:1421.
- La'ulu SL, Rawlins ML, Pfeiffer CM, et al. Performance characteristics of six homocysteine assays. Am J Clin Pathol. 2008;130(6):969–975.
- CLSI. Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline‐Third Edition. CLSI document EP05‐A3. 2014.
- CLSI. Measurement procedure comparison and bias estimation using patient samples; Approved guideline-Third Edition. CLSI document EP09-A3. 2013.
- CLSI. Evaluation of the linearity of quantitative measurement procedures: a statistical approach. Approved Guideline. CLSI document EP06-A. 2003.
- CLSI. Preliminary Evaluation of Quantitative Clinical Laboratory Measurement Procedures; Approved Guideline-Third Edition. CLSI document EP10‐A3. 2006.
- CLSI. Establishing, and verifying reference intervals in the clinical laboratory. Approved Guidline-Third Edition. CLSI Document C28-A3. Pennsylvania, PA: CLSI; 2008.
- Wf J. Westgard QC. [cited 2020 Feb 20]. Available from: http://www.westgard.com/biodatabase1.htm.
- Ubbink JB. Assay methods for the measurement of total homocyst(e)ine in plasma. Semin Thromb Hemost. 2000;26(3):233–241.
- Frantzen F, Faaren AL, Alfheim I, et al. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem. 1998;44(2):311–316.
- Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem. 1995;41(7):991–994.
- Price T, Beatty BG, Beatty JD, et al. Human anti-murine antibody interference in measurement of carcinoembryonic antigen assessed with a double-antibody enzyme immunoassay. Clin Chem. 1991;37(1):51–57.
- Boscato LM, Stuart MC. Heterophilic antibodies: a problem for all immunoassays. Clin Chem. 1988;34(1):27–33.
- Clarke R, Bennett DA, Parish S, for the MTHFR Studies Collaborative Group, et al. Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med. 2012;9(2):e1001177.
- Li Y, Huang T, Zheng Y, et al. Folic acid supplementation and the risk of cardiovascular diseases: a meta‐analysis of randomized controlled trials. J Am Heart Assoc. 2016;5(8):e003768.
- Karger AB, Steffen BT, Nomura SO, et al. Association between homocysteine and vascular calcification incidence, prevalence, and progression in the MESA Cohort. J Am Heart Assoc. 2020;9(3):e013934.
- Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004;50(1):3–32.